Loading...

FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11

October 29, 2021 by Dan McCue
FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11
In this June 6, 2021 file photo, a youth receives a Pfizer-BioNTech COVID-19 vaccine in the central Israeli city of Rishon LeZion. (AP Photo/Sebastian Scheiner)

WASHINGTON — The Food and Drug Administration on Friday authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 to 11.

“As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization,” said Acting FDA Commissioner Dr. Janet Woodcock in a written statement announcing the decision.

“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” Woodcock continued, adding, “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”

If the Centers for Disease Control and Prevention signs off, as is expected when its Advisory Committee on Immunization Practices meets next week, children could start getting shots as early as Wednesday.

The FDA said in a press release Friday that children 5 to 11 would be administered a two-dose primary series, three weeks apart, but at a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30 micrograms).

The agency went on to say that in a study involving 3,100 children aged 5 to 11, the immune response was comparable to those in earlier studies on individuals aged 16 to 25. In that study, the vaccine was deemed to be about 90.7% effective.

In addition, the FDA said no serious adverse effects have been detected in the ongoing study.

The Biden administration has promised that children’s shots will be easily accessible at pediatrician offices, community health centers, children’s hospitals and pharmacies, with 15 million doses ready to ship immediately.

States started ordering doses last week, under a formula based on how many children they have in the age group. While the school year is already well underway, the pediatric dose is arriving in time for the holidays, giving more comfort to families looking to gather older and younger people together for the first time since the early months of 2020.

According to the CDC, COVID-19 cases in children 5 to 11 comprise about 39% of cases in individuals younger than 18 years of age. 

In addition, the Centers said approximately 8,300 COVID-19 cases in children 5 to 11 resulted in hospitalization. 

As of Oct. 17, 691 deaths from COVID-19 have been reported in the U.S. in individuals younger than 18 years of age, with 146 deaths in the 5 to 11 age group, the CDC said.

“Today is a momentous day in the fight against the COVID-19 pandemic, with the FDA’s first emergency use authorization of a coronavirus vaccine for younger children,” House Speaker Nancy Pelosi said in a statement. 

“Congress and the country are grateful to our scientists and health officials, who worked quickly and carefully to ensure that the Pfizer vaccine is safe and effective for our youngest Americans,” she said. “Getting our children vaccinated is the best way to ensure their health and safety, so they can go to school, spend time with their families and engage in our communities with the confidence of knowing they are protected from this vicious virus.

“It is heartbreaking that more than a thousand Americans lose their lives to this virus each day, nearly all of whom were unvaccinated. It is now crucial that every eligible American — especially children ages five to eleven — get vaccinated as quickly as possible, so that we can finally put an end to this pandemic,” Pelosi added.

Dan can be reached at dan@thewellnews.com and at https://twitter.com/DanMcCue

In The News

Health

Voting

Health

January 14, 2022
by Dan McCue
White House Announces Plans to Distribute Home COVID Tests

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government,... Read More

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government, a senior White House official announced Friday afternoon. In the early going of the new program, individuals will be limited to four free tests per residential... Read More

Mask Rules Get Tighter in Europe in Winter's COVID-19 Wave

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with... Read More

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with a vigorous “yes." Now the onetime epicenter of the pandemic in Europe hopes even stricter mask rules will help it beat the latest infection surge. Other... Read More

January 12, 2022
by Reece Nations
House Rules Committee Rejects G.I. Bill Education Benefits for Vaccine Refusal

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act... Read More

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act that would guarantee Armed Services members discharged for refusing the COVID-19 vaccine are eligible for G.I. Bill education benefits. The Guard and Reserve G.I. Bill Parity... Read More

January 12, 2022
by Alexa Hornbeck
Reliability of Antigen Rapid Tests in Detecting Early Omicron Questioned

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite... Read More

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite recent concerns from elected officials and researchers over the reliability and availability of rapid antigen testing. “I’ve heard from so many people who are waiting in... Read More

January 12, 2022
by Alexa Hornbeck
COVID Pills Show Promise for Combating Severe Infection

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health... Read More

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health show the pill may hold promise in saving lives. Shortly before Christmas Day, Paxlovid was authorized for at-home treatment of high-risk COVID-19 infections in patients over... Read More

January 12, 2022
by Alexa Hornbeck
Researchers Develop mRNA-based Lyme Disease Vaccine

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability... Read More

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability to transmit pathogens.  According to the CDC, nearly half a million people in the U.S. are diagnosed with Lyme Disease every year. The ailment is most... Read More

News From The Well
Exit mobile version